Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umberto Vitolo

Showing results (81-90 of 212) with videos related to

Pageof 22
Sort By:
Annals of Hematology|April 18, 2018
Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experienceChiara Ciochetto, Barbara Botto, Roberto Passera, et al.
Experimental Hematology|September 10, 2003
Recurrence of Bcl-2/IgH polymerase chain reaction positivity following a prolonged molecular remission can be unrelated to the original follicular lymphoma cloneMarco Ladetto, Barbara Mantoan, Irene Ricca, et al.
Cancer|December 20, 2011
Fludarabine, cyclophosphamide, and rituximab in patients with advanced, untreated, indolent B-cell nonfollicular lymphomas: phase 2 study of the Italian Lymphoma FoundationAndrea Ferrario, Alessandro Pulsoni, Barbara Olivero, et al.
British Journal of Haematology|June 19, 2018
Genomic alterations of ribosomal protein genes in diffuse large B cell lymphomaEnrico Derenzini, Claudio Agostinelli, Alessandra Rossi, et al.
Leukemia & Lymphoma|December 16, 2020
Evaluation of the effect of prospective biomarker testing on progression-free survival in diffuse large B-cell lymphomaEdith Szafer-Glusman, Juan Liu, Arijit Sinha, et al.
Leukemia & Lymphoma|September 23, 2014
Lenalidomide monotherapy in heavily pretreated patients with non-Hodgkin lymphoma: an Italian observational multicenter retrospective study in daily clinical practicePier Luigi Zinzani, Luigi Rigacci, Maria Cristina Cox, et al.
Journal of Chemotherapy (Florence, Italy)|October 1, 2013
Prevention of invasive fungal infections in patients with acute myeloid leukaemia: results of a single centre retrospective observational study with the use of posaconazole versus conventional mould-active azolesChiara Maria Dellacasa, Alessandro Busca, Ernesta Audisio, et al.
Blood Advances|April 17, 2020
Impact of bone marrow biopsy on response assessment in immunochemotherapy-treated lymphoma patients in GALLIUM and GOYASarah C Rutherford, Michael Herold, Wolfgang Hiddemann, et al.
Haematologica|May 7, 2013
Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trialsPier Luigi Zinzani, Simonetta Viviani, Antonella Anastasia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2006
Phase III intergroup study of fludarabine phosphate compared with cyclophosphamide, vincristine, and prednisone chemotherapy in newly diagnosed patients with stage III and IV low-grade malignant Non-Hodgkin's lymphomaAnton Hagenbeek, Houchingue Eghbali, Silvio Monfardini, et al.
Pageof 22

Showing results (81-90 of 212) with videos related to

Sort By:
Pageof 22
Annals of Hematology|April 18, 2018
Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experienceChiara Ciochetto, Barbara Botto, Roberto Passera, et al.
Experimental Hematology|September 10, 2003
Recurrence of Bcl-2/IgH polymerase chain reaction positivity following a prolonged molecular remission can be unrelated to the original follicular lymphoma cloneMarco Ladetto, Barbara Mantoan, Irene Ricca, et al.
Cancer|December 20, 2011
Fludarabine, cyclophosphamide, and rituximab in patients with advanced, untreated, indolent B-cell nonfollicular lymphomas: phase 2 study of the Italian Lymphoma FoundationAndrea Ferrario, Alessandro Pulsoni, Barbara Olivero, et al.
British Journal of Haematology|June 19, 2018
Genomic alterations of ribosomal protein genes in diffuse large B cell lymphomaEnrico Derenzini, Claudio Agostinelli, Alessandra Rossi, et al.
Leukemia & Lymphoma|December 16, 2020
Evaluation of the effect of prospective biomarker testing on progression-free survival in diffuse large B-cell lymphomaEdith Szafer-Glusman, Juan Liu, Arijit Sinha, et al.
Leukemia & Lymphoma|September 23, 2014
Lenalidomide monotherapy in heavily pretreated patients with non-Hodgkin lymphoma: an Italian observational multicenter retrospective study in daily clinical practicePier Luigi Zinzani, Luigi Rigacci, Maria Cristina Cox, et al.
Journal of Chemotherapy (Florence, Italy)|October 1, 2013
Prevention of invasive fungal infections in patients with acute myeloid leukaemia: results of a single centre retrospective observational study with the use of posaconazole versus conventional mould-active azolesChiara Maria Dellacasa, Alessandro Busca, Ernesta Audisio, et al.
Blood Advances|April 17, 2020
Impact of bone marrow biopsy on response assessment in immunochemotherapy-treated lymphoma patients in GALLIUM and GOYASarah C Rutherford, Michael Herold, Wolfgang Hiddemann, et al.
Haematologica|May 7, 2013
Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trialsPier Luigi Zinzani, Simonetta Viviani, Antonella Anastasia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2006
Phase III intergroup study of fludarabine phosphate compared with cyclophosphamide, vincristine, and prednisone chemotherapy in newly diagnosed patients with stage III and IV low-grade malignant Non-Hodgkin's lymphomaAnton Hagenbeek, Houchingue Eghbali, Silvio Monfardini, et al.
Pageof 22